Skip to content

A cross-sectional survey on genetic counseling and genetic testing in hemophilia carrier care in Japan

A cross-sectional survey on genetic counseling and genetic testing in hemophilia carrier care in Japan - A cross-sectional survey on genetic counseling and genetic testing in hemophilia carrier care in Japan

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000060633
Enrollment
109
Registered
2026-02-09
Start date
2026-01-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemophilia

Interventions

None listed

Sponsors

Tokyo Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The physician representative of each block core hospital designated by the Hemophilia Care Network Committee of the Japan Society on Thrombosis and Hemostasis (17 institutions, excluding Tokyo Medical University Hospital). The physician representative of each regional core hospital designated by the Hemophilia Care Network Committee of the Japan Society on Thrombosis and Hemostasis (92 institutions).

Exclusion criteria

Exclusion criteria: Individuals who do not provide consent to participate in the questionnaire (i.e., do not agree / do not check the consent box)

Design outcomes

Primary

MeasureTime frame
Whether each institution provides (1) genetic counseling and (2) genetic testing-based hemophilia carrier diagnosis.

Countries

Japan

Contacts

Public ContactMasato Bingo

Tokyo Medical University Department of Laboratory Medicine

bingo@tokyo-med.ac.jp0333426111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026